Bausch + Lomb Reports Revenue Growth in 2025 Third Quarter, Confirms Full-Year Outlook
Published on October 30, 2025
VAUGHN, Ontario—Eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) announced third-quarter financial results on Wednesday for the three months ending September 30, 2025. The company reported total revenue of $1.281 billion for the third quarter, an increase of $85 million, or 7 percent, compared with $1.196 billion in the third quarter of 2024. This growth was driven by all segments—vision care, surgical, and pharmaceutical—resulting in a 6 percent year-over-year revenue increase on a constant currency basis, the company advised.